The most recent version of MarkNtel Advisors' research report on the Liquid Biopsy market includes an examination of numerous aspects that contribute to the market's growth, analysis, size, share, outlook and expected to grow at CAGR of 26% by 2028.  It includes trends, limitations, and market drivers that have an impact on the market, either positively or negatively. The report provides scope for strategic planning and presents a complete assessment of constraints, restraints, and possibilities. The industry growth factors are crucial since they may be comprehended to create various tactics for seizing the lucrative prospects present in the constantly expanding industry. In order to better understand the market and make useful recommendations, the views of market experts have also been considered.

Try Before You Buy: Get Your Free Sample Report Today! -

How large is the Liquid Biopsy market?

Growth Rate: 26% CAGR

Year of Estimation Base: 2022

Historical Information: 2018-2021

Projection Period:2023-2028

Driving Factors for the Liquid Biopsy Market and an Analysis of Future Demand:

Key Driver: Global Surge in Cancer Cases

The number of cancer cases has surged significantly on a global scale. Environmental factors are the leading causes of cancer. The rise in cancer diagnosis has led various countries and international health organizations to undertake various initiatives to spread awareness about cancer. With this increase, Liquid biopsy is preferred for its multiple advantages, counting low-cost, early prognosis, tumor heterogeneity identification, drug resistance, therapeutic drug monitoring, and the most ascendant, patient comfort by eliminating the need for surgery. Consecutively, this increase in preference for Liquid Biopsies is expected to increase the Market during the forecasting period.

Possible Restraint: Compatibility of Liquid Biopsies with Specific Kinds and Stages of Cancer

Detecting ctDNA through Liquid Biopsy becomes technically tricky as the quantities of ctDNA may be lower in the plasma of a cancer patient for particular cancer mutations, especially after the treatment and surgery. It is also not applicable to all cancers, as certain tumors do not shed a recognizable amount of ctDNA. Also, there may be fewer than one detectable copy of the cancer mutation containing ctDNA in a patient’s sample, resulting in ctDNA not being identified, even though ctDNA is deficient. As a result, the credibility is lessened, as it might give a false negative where ctDNA is not identifiable. This discrepancy could negatively hinder the market.

Note - You will find a thorough market analysis, growth analysis graphs, historical and forecast period analyses, key market segmentation, the top key players in the market, a table of contents, a list of figures, and a list of tables in this research reports.

Dig Deeper into the Data: Access the Full Report with Detailed Analysis! -

Discovering Potential: Unraveling Segments and Regional and Country projections in the Liquid Biopsy Market

The Liquid Biopsy Market can be divided into different Segments, along with different regions/country. The growth of each segment provides a precise estimation and sales forecast for the period from 2023 to 2028. This analysis is valuable for stakeholders aiming to expand their businesses by focusing on specific and qualified niche markets. The report includes market data at regional levels. Our team of research analysts comprehends the competitive advantages of each competitor and offers a separate competitive analysis for each.

What Exactly Does Liquid Biopsy Market Segmentation Include?

By Work Process

-Sample Preparation              

-Library Preparation


-Data Analysis        

By Technology




--Multiplex PCR




-Other Technologies

By Usage



By Sample Type




-Cerebrospinal Fluid

By Products

-Test /Services

-Kits and Consumables


By Circulating Biomarkers

-Circulating Tumor Cells

-Cell-free DNA

-Circulating Cell-Free RNA  

-Exosomes and Extracellular Vesicles          


By Disease Type

-Lung Cancer

-Breast Cancer

-Prostate Cancer

-Colorectal Cancer


-Other Cancers

-Non-Oncology Disorders

By Clinical Application

-Treatment Monitoring

-Prognosis and Recurrence Monitoring

-Treatment Selection

-Diagnosis and Screening

Geographical Analysis Trends, Future and Forecast (2023-2028) of Liquid Biopsy Market

By Region

-North America

-South America


-Middle East & Africa


Who Are the Leading Key Players in the Liquid Biopsy Market

The report has also examined the competitive landscape of the market, highlighting key players -

-Bio-Rad Laboratories

-Biocept Inc

-Abcodia Ltd

-Chronix Biomedical

-Epic Sciences Inc

-Hoffmann-La Roche AG 

-Cynvenio Biosystems, Inc.         


-Illumina, Inc.

-NeoGenomics Laboratories, Inc.

-Menarini Silicon Biosystems, Inc.

-Qiagen N.V.

-Thermo Fisher Scientific

-Personal Genome Diagnostics, Inc.

- Qiagen N.V.

Expert Guidance at Your Fingertips: Talk to Our Consultants Today! –

Important advantages for stakeholders

  • In order to identify the potential in the present market, this study aims to provide a thorough analysis of the current market trends and future projections from 20023 to 2028.
  • A thorough analysis of numerous locations that yields information that can help organisations plan their commercial actions tactically.
  • A thorough study and projections of different regions to give stakeholders a thorough understanding of the present trends so they may create region-specific plans.
  • Important regulatory processes for the market under study are carefully considered based on the region.
  • A thorough study of the elements supporting and impeding the expansion of the Liquid Biopsy market is given.

Do not miss out the business opportunity of Liquid Biopsy Market. Consult our analysts to gather imperative insights, and facilitate your business growth.

About MarkNtel Advisors

MarkNtel Advisors is a leading research, consulting, & data analytics firm that provides an extensive range of strategic reports on diverse industry verticals. We deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, & individuals, among others.

Our specialization in niche industries & emerging geographies allows our clients to formulate their strategies in a much more informed way and entail parameters like Go-to-Market (GTM), product development, feasibility analysis, project scoping, market segmentation, competitive benchmarking, market sizing & forecasting, & trend analysis, among others, for 15 diverse industrial verticals. Using such information, our clients can identify attractive investment opportunities & strategize their moves to yield higher ROI (Return of Interest) through an early mover advantage with top-management approaches.

Contact us:

If you have any questions, our team of trained and professional experts is here to help. You can get in touch with us by calling, sending an email, or using our online contact form.

We will try our best to answer your request as quickly as we can and give you the details you require.

Company Name: MarkNtel Advisors

Email: Send Email

Phone: +1 628 895 8081 +91 120 4268433,

Address: 5214F Diamond Heights Blvd #3092,

San Francisco, CA 94131

United States